-
Patent Agency Ranking
公开(公告)号：EP1619192A3
公开(公告)日：2006-03-22
申请号：EP05106835.1
申请日：2001-02-08
Applicant: Pfizer Products Inc.
Inventor： Brooks, Paige, Roanne, Palmer , Coe, Jotham, Wadsworth
IPC: C07D471/08 , C07D498/08 , C07D513/08 , A61K31/435 , C07D221/22 , C07D235/00 , C07D221/00 , C07D263/00 , C07D277/00 , C07D241/00
CPC classification number: C07D513/08 , C07D221/22 , C07D221/24 , C07D231/12 , C07D233/56 , C07D249/08 , C07D413/04 , C07D471/08
Abstract: The invention relates to compounds of the formula
and their pharmaceutically acceptable salts, wherein R 1 , R 2 , and R 3 are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of neurological and psychological disorders.Abstract translation: 本发明涉及下式的化合物及其药学上可接受的盐，其中R 1，R 2和R 3如本文所定义; 用于合成这些化合物的中间体，含有这些化合物的药物组合物; 以及使用这些化合物治疗神经和心理疾病的方法。
-
2.发明公开PROCESS FOR THE PREPARATION OF BICYCLO[3.2.1]OCTANE FUSED WITH QUINAZOLINE DERIVATIVES 审中-公开PROCESS FOR WITH喹唑啉衍生物生成浓缩双环[3.2.1]辛烷
公开(公告)号：EP1659114A3
公开(公告)日：2007-01-17
申请号：EP05106853.4
申请日：1998-11-13
Applicant: Pfizer Products Inc.
Inventor： Coe, Jotham, Wadsworth , Brooks, Paige, Roanne, Palmer
IPC: A61K31/435 , C07D498/08 , C07D221/22
CPC classification number: C07D221/24 , A61K31/473 , C07D221/22 , C07D471/08 , C07D513/08
Abstract: The invention relates to a process for the preparation of a compound of formula IC
-
公开(公告)号：EP1619192B1
公开(公告)日：2009-12-30
申请号：EP05106835.1
申请日：2001-02-08
Applicant: Pfizer Products Inc.
Inventor： Brooks, Paige, Roanne, Palmer , Coe, Jotham, Wadsworth
IPC: C07D471/08 , C07D498/08 , C07D513/08 , A61K31/435 , C07D221/22
CPC classification number: C07D513/08 , C07D221/22 , C07D221/24 , C07D231/12 , C07D233/56 , C07D249/08 , C07D413/04 , C07D471/08
-
4.发明公开Process for the preparation of Bicyclo[3.2.1]octane fused with quinazoline derivatives 审中-公开VERFAHREN ZUR HERSTELLUNG VON MIT CHINAZOLINDERIVATEN KONDENSIERTEM BICYCLO [3.2.1] OKTAN
公开(公告)号：EP1659114A2
公开(公告)日：2006-05-24
申请号：EP05106853.4
申请日：1998-11-13
Applicant: Pfizer Products Inc.
Inventor： Coe, Jotham, Wadsworth , Brooks, Paige, Roanne, Palmer
IPC: C07D221/22 , A61K31/435 , C07D471/08 , C07D498/08 , C07D513/08
CPC classification number: C07D221/24 , A61K31/473 , C07D221/22 , C07D471/08 , C07D513/08
Abstract: The invention relates to a process for the preparation of a compound of formula IC
Abstract translation: 本发明涉及制备式IC化合物的方法
-
公开(公告)号：EP1619192A2
公开(公告)日：2006-01-25
申请号：EP05106835.1
申请日：2001-02-08
Applicant: Pfizer Products Inc.
Inventor： Brooks, Paige, Roanne, Palmer , Coe, Jotham, Wadsworth
IPC: C07D471/08 , C07D498/08 , C07D513/08 , A61K31/435 , C07D221/22 , C07D235/00 , C07D221/00 , C07D263/00 , C07D277/00 , C07D241/00
CPC classification number: C07D513/08 , C07D221/22 , C07D221/24 , C07D231/12 , C07D233/56 , C07D249/08 , C07D413/04 , C07D471/08
Abstract: The invention relates to compounds of the formula
and their pharmaceutically acceptable salts, wherein R 1 , R 2 , and R 3 are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of neurological and psychological disorders.Abstract translation: 本发明涉及下式化合物及其药学上可接受的盐，其中R 1，R 2和R 3如本文所定义; 用于合成这些化合物的中间体，含有这些化合物的药物组合物; 以及使用这些化合物治疗神经和心理障碍的方法。
-
-
-
-
Search Results
5
records
(took 0.016 seconds)
